{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:45:24Z","timestamp":1743122724670,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":40,"publisher":"Springer Nature Singapore","isbn-type":[{"type":"print","value":"9789819713349"},{"type":"electronic","value":"9789819713356"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-981-97-1335-6_18","type":"book-chapter","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T19:02:17Z","timestamp":1709665337000},"page":"200-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a Novel Model for Predicting the Prognosis and Immune Response Based on Genes Related to Ferroptosis and Disulfidptosis in Liver Hepatocellular Carcinoma"],"prefix":"10.1007","author":[{"given":"Xiaohui","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"18_CR1","doi-asserted-by":"publisher","unstructured":"Sung, H.: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3): 209\u2013249 (2021). https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"18_CR2","doi-asserted-by":"publisher","unstructured":"Ganesan, P., Kulik, L.M.: Hepatocellular carcinoma: new developments. Clin. Liver disease 27(1), 85\u2013102 (2023). https:\/\/doi.org\/10.1016\/j.cld.2022.08.004","DOI":"10.1016\/j.cld.2022.08.004"},{"key":"18_CR3","doi-asserted-by":"publisher","unstructured":"Laface, C., et al.: Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. Cancers, 14(16), 4028 (2022).https:\/\/doi.org\/10.3390\/cancers14164028","DOI":"10.3390\/cancers14164028"},{"key":"18_CR4","doi-asserted-by":"publisher","unstructured":"Sangro, B., Sarobe, P., Herv\u00e1s-Stubbs, S., Melero, I.: Advances in immunotherapy for hepatocellular carcinoma. Nature Rev.. Gastroenterol. Hepatol. 18(8): 525\u2013543 (2021). https:\/\/doi.org\/10.1038\/s41575-021-00438-0","DOI":"10.1038\/s41575-021-00438-0"},{"key":"18_CR5","doi-asserted-by":"publisher","unstructured":"Liu X, et al.: Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nature Cell Biol. 25(3), 404\u2013414 (2023). https:\/\/doi.org\/10.1038\/s41556-023-01091-2","DOI":"10.1038\/s41556-023-01091-2"},{"key":"18_CR6","doi-asserted-by":"publisher","unstructured":"Zhao, S., et al.: Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework. Front. Endocrinol. 14 1180404 (2023). https:\/\/doi.org\/10.3389\/fendo.2023.1180404","DOI":"10.3389\/fendo.2023.1180404"},{"key":"18_CR7","doi-asserted-by":"publisher","unstructured":"Qi, C., Ma, J., Sun, J., Wu, X., Ding, J.: The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma. Aging 15(11), 5075\u20135095 (2023). https:\/\/doi.org\/10.18632\/aging.204782","DOI":"10.18632\/aging.204782"},{"key":"18_CR8","doi-asserted-by":"publisher","unstructured":"Liu, L, et al.: Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer. Sci. Reports 13(1), 12470 (2023). https:\/\/doi.org\/10.1038\/s41598-023-39669-3","DOI":"10.1038\/s41598-023-39669-3"},{"key":"18_CR9","doi-asserted-by":"publisher","unstructured":"Tang, D., Chen, X., Kang, R., Kroemer, G.: Ferroptosis: molecular mechanisms and health implications. Cell Res. 31(2), 107\u2013125 (2021). https:\/\/doi.org\/10.1038\/s41422-020-00441-1","DOI":"10.1038\/s41422-020-00441-1"},{"key":"18_CR10","doi-asserted-by":"publisher","unstructured":"Liang, C., Zhang, X., Yang, M., Dong, X.: Recent progress in ferroptosis inducers for cancer therapy. Advanced materials (Deerfield Beach, Fla.). 31(51), e1904197 (2019). https:\/\/doi.org\/10.1002\/adma.201904197","DOI":"10.1002\/adma.201904197"},{"key":"18_CR11","doi-asserted-by":"publisher","unstructured":"Liang, J.Y., et al.: A novel ferroptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma. Int. J. Biol. Sci. 16(13): 2430\u20132441 (2020). https:\/\/doi.org\/10.7150\/ijbs.45050","DOI":"10.7150\/ijbs.45050"},{"key":"18_CR12","doi-asserted-by":"publisher","unstructured":"Li, C.: SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination. J. Exper. Clin. Cancer Res. CR, 38(1), 76 (2019). https:\/\/doi.org\/10.1186\/s13046-019-1069-3","DOI":"10.1186\/s13046-019-1069-3"},{"key":"18_CR13","doi-asserted-by":"publisher","unstructured":"Zhou, N., Bao, J.: FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database : J. Biol. Databases Curation 2020, baaa021 (2020). https:\/\/doi.org\/10.1093\/database\/baaa021","DOI":"10.1093\/database\/baaa021"},{"key":"18_CR14","doi-asserted-by":"publisher","unstructured":"Keyhanmanesh, R., Hamidian, G., Alipour, M.R., Ranjbar, M., Oghbaei, H.: Protective effects of sodium nitrate against testicular apoptosis and spermatogenesis impairments in streptozotocin-induced diabetic male rats. Life sciences, 211, 63\u201373. (2018). https:\/\/doi.org\/10.1016\/j.lfs.2018.09.019","DOI":"10.1016\/j.lfs.2018.09.019"},{"key":"18_CR15","doi-asserted-by":"publisher","unstructured":"Fang, J., Chen, F., Liu, D., Gu, F., Chen, Z., Wang, Y.: Prognostic value of immune checkpoint molecules in breast cancer. Biosci. Reports 40(7): BSR20201054 (2020). https:\/\/doi.org\/10.1042\/BSR20201054","DOI":"10.1042\/BSR20201054"},{"key":"18_CR16","doi-asserted-by":"publisher","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. (2022). Hepatocellular carcinoma. Lancet (London, England), 400 (10360), 1345\u20131362. https:\/\/doi.org\/10.1016\/S0140-6736(22)01200-4","DOI":"10.1016\/S0140-6736(22)01200-4"},{"key":"18_CR17","doi-asserted-by":"publisher","unstructured":"Couri, T., Pillai, A.: Goals and targets for personalized therapy for HCC. Hepatology international, 13(2): 125\u2013137 (2019). https:\/\/doi.org\/10.1007\/s12072-018-9919-1","DOI":"10.1007\/s12072-018-9919-1"},{"key":"18_CR18","doi-asserted-by":"publisher","unstructured":"Meng, Y., Chen, X., Deng, G.: Disulfidptosis: a new form of regulated cell death for cancer treatment. Mol. Biomed. 4(1), 18 (2023). https:\/\/doi.org\/10.1186\/s43556-023-00132-4","DOI":"10.1186\/s43556-023-00132-4"},{"key":"18_CR19","doi-asserted-by":"publisher","unstructured":"Wang, L., Hensley, C.R., HowellM, M.E., Ning, S.: Bioinformatics-Driven Identification of p62 as a crucial Oncogene in Liver Cancer. Front. Oncol. 12, 923009 (2022). https:\/\/doi.org\/10.3389\/fonc.2022.923009","DOI":"10.3389\/fonc.2022.923009"},{"key":"18_CR20","doi-asserted-by":"publisher","unstructured":"Oyadomari, S., Mori, M.: Roles of CHOP\/GADD153 in endoplasmic reticulum stress. Cell death and differentiation, 11(4), 381\u2013389 (2004). https:\/\/doi.org\/10.1038\/sj.cdd.4401373","DOI":"10.1038\/sj.cdd.4401373"},{"key":"18_CR21","doi-asserted-by":"publisher","unstructured":"Xiao, F., et al.: Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1\/2-EGR1\/DDIT3 signaling cascade. Sci. Reports 11(1), 488 (2021). https:\/\/doi.org\/10.1038\/s41598-020-80066-x","DOI":"10.1038\/s41598-020-80066-x"},{"key":"18_CR22","doi-asserted-by":"publisher","unstructured":"Shen, Z., et al.: Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress. Cellular Oncol. (Dordrecht), 44(5), 1035\u20131049 (2021). https:\/\/doi.org\/10.1007\/s13402-021-00617-w","DOI":"10.1007\/s13402-021-00617-w"},{"key":"18_CR23","doi-asserted-by":"publisher","unstructured":"Li, G., Tian, Y., Gao, Z.: The role of AURKA\/miR-199b-3p in hepatocellular carcinoma cells. J. Clin. Lab. Anal. 36(12), e24758 (2022). https:\/\/doi.org\/10.1002\/jcla.24758","DOI":"10.1002\/jcla.24758"},{"key":"18_CR24","doi-asserted-by":"publisher","unstructured":"Shen, H.M., Zhang, D., Xiao, P., Qu, B., Sun, Y.F.: E2F1-mediated KDM4A-AS1 up-regulation promotes EMT of hepatocellular carcinoma cells by recruiting ILF3 to stabilize AURKA mRNA. Cancer Gene Therapy, 30(7), 1007\u20131017 (2023). https:\/\/doi.org\/10.1038\/s41417-023-00607-0","DOI":"10.1038\/s41417-023-00607-0"},{"key":"18_CR25","doi-asserted-by":"publisher","unstructured":"Li, G., et al.: LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nature cell biology, 23(5), 526\u2013537 (2021). http:\/\/https:\/\/doi.org\/10.1038\/s41556-021-00672-3","DOI":"10.1038\/s41556-021-00672-3"},{"key":"18_CR26","doi-asserted-by":"publisher","unstructured":"Fan, R., et al.: Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors. J. Trans. Med. 10 101 (2012). https:\/\/doi.org\/10.1186\/1479-5876-10-101","DOI":"10.1186\/1479-5876-10-101"},{"key":"18_CR27","doi-asserted-by":"publisher","unstructured":"Mou, L., et al.: Clinical and Prognostic Value of PPIA, SQSTM1, and CCL20 in Hepatocellular Carcinoma Patients by Single-Cell Transcriptome Analysis. Cells 11(19), 3078 (2022). https:\/\/doi.org\/10.3390\/cells11193078","DOI":"10.3390\/cells11193078"},{"key":"18_CR28","doi-asserted-by":"publisher","unstructured":"Wang, X., et al.: The NQO1\/p53\/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability. Oncogene. 41(47), 5107\u20135120 (2022). https:\/\/doi.org\/10.1038\/s41388-022-02477-6","DOI":"10.1038\/s41388-022-02477-6"},{"issue":"5","key":"18_CR29","first-page":"1698","volume":"13","author":"C Deng","year":"2023","unstructured":"Deng, C., Gong, S., Lin, L., Tang, J., Pang, X., Wu, P.: A human pan-cancer system analysis of heat shock protein family a member 5. Am. J. Cancer Res. 13(5), 1698\u20131717 (2023)","journal-title":"Am. J. Cancer Res."},{"key":"18_CR30","doi-asserted-by":"publisher","unstructured":"Aran, G., et al.: CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78). FASEB J.: Off. Public. Fed.. Am. Societies Exper. Biol. 32(7), 3878\u20133891. https:\/\/doi.org\/10.1096\/fj.201700941RR","DOI":"10.1096\/fj.201700941RR"},{"key":"18_CR31","doi-asserted-by":"publisher","unstructured":"Zhu, R.K., Zhang, W., Zhang, Y.X,. Hui, Z., Wang, X.W.: A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5. Current cancer drug targets (2023). https:\/\/doi.org\/10.2174\/1568009623666230508111721","DOI":"10.2174\/1568009623666230508111721"},{"issue":"10","key":"18_CR32","first-page":"6924","volume":"14","author":"H Sun","year":"2022","unstructured":"Sun, H., et al.: Novel prognostic signature based on HRAS, MAPK3 and TFRC identified to be associated with ferroptosis and the immune microenvironment in hepatocellular carcinoma. Am. J. Transl. Res. 14(10), 6924\u20136940 (2022)","journal-title":"Am. J. Transl. Res."},{"key":"18_CR33","doi-asserted-by":"publisher","unstructured":"Kondapuram, S.K., Coumar, M.S.: Pan-cancer gene expression analysis: Identification of deregulated autophagy genes and drugs to target them. Gene 844, 146821 (2022). https:\/\/doi.org\/10.1016\/j.gene.2022.146821","DOI":"10.1016\/j.gene.2022.146821"},{"key":"18_CR34","doi-asserted-by":"publisher","unstructured":"Khemlina, G., Ikeda, S., Kurzrock, R.: The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Mol. Cancer, 16(1), 149 (2017). https:\/\/doi.org\/10.1186\/s12943-017-0712-x","DOI":"10.1186\/s12943-017-0712-x"},{"key":"18_CR35","doi-asserted-by":"publisher","unstructured":"Zhou, Y., Wang, X.B., Qiu, X.P., Zhang, S., Wang, C., Zheng, F.: CDKN2A promoter methylation and hepatocellular carcinoma risk: a meta-analysis. Clin. Res. Hepatol. Gastroenterol. 42(6), 529\u2013541 (2018). https:\/\/doi.org\/10.1016\/j.clinre.2017.07.003","DOI":"10.1016\/j.clinre.2017.07.003"},{"key":"18_CR36","doi-asserted-by":"publisher","unstructured":"Raposo, T.P., Beir\u00e3o, B.C.B., Pang, L.Y., Queiroga, F.L., Argyle, D.J.: Inflammation and cancer: till death tears them apart. Veterinary J. (London, England : 1997), 205(2), 161\u2013174 (2015). https:\/\/doi.org\/10.1016\/j.tvjl.2015.04.015","DOI":"10.1016\/j.tvjl.2015.04.015"},{"key":"18_CR37","doi-asserted-by":"publisher","unstructured":"Garufi, G., et al.: Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors. Expert Opinion Pharmacother. 21(6), 687\u2013699 (2020). https:\/\/doi.org\/10.1080\/14656566.2020.1724957","DOI":"10.1080\/14656566.2020.1724957"},{"key":"18_CR38","doi-asserted-by":"publisher","unstructured":"Kaushik, I., Ramachandran, S., Zabel, C., Gaikwad, S., Srivastava, S.K.: The evolutionary legacy of immune checkpoint inhibitors. Seminars in cancer biology, 86(Pt 2), 491\u2013498 (2022). https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.020","DOI":"10.1016\/j.semcancer.2022.03.020"},{"key":"18_CR39","doi-asserted-by":"publisher","unstructured":"Li, Y., et al.: Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers. Nature Commun. 11(1), 1000 (2020). https:\/\/doi.org\/10.1038\/s41467-020-14802-2","DOI":"10.1038\/s41467-020-14802-2"},{"key":"18_CR40","doi-asserted-by":"publisher","unstructured":"Zhou, M., Zhang, Z., Zhao, H., Bao, S., Cheng, L., Sun, J.: An immune-related six-lncRNA signature to improve prognosis prediction of glioblastoma multiforme. Mol. Neurobiol. 55(5), 3684\u20133697 (2018). https:\/\/doi.org\/10.1007\/s12035-017-0572-9","DOI":"10.1007\/s12035-017-0572-9"}],"container-title":["Lecture Notes in Electrical Engineering","Proceedings of 2023 International Conference on Medical Imaging and Computer-Aided Diagnosis (MICAD 2023)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-97-1335-6_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T19:06:49Z","timestamp":1709665609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-97-1335-6_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9789819713349","9789819713356"],"references-count":40,"URL":"https:\/\/doi.org\/10.1007\/978-981-97-1335-6_18","relation":{},"ISSN":["1876-1100","1876-1119"],"issn-type":[{"type":"print","value":"1876-1100"},{"type":"electronic","value":"1876-1119"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"6 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"MICAD","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Medical Imaging and Computer-Aided Diagnosis","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Cambridge","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"United Kingdom","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2023","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"9 December 2023","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"10 December 2023","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"micad2023","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}